Jump to content
Knowledge Hub

News Archive

Concept paper on revision of the guidelines on good manufacturing practice for medicinal products - annex 6 manufacture of medicinal gases

18th February 2026

Consultation open: 11/02/2026 to 11/04/2026

Read More+

Concept paper on the revision of the guidelines on Good Manufacturing Practice for medicinal products - Annex 15 - Qualification and validation

18th February 2026

Consultation dates: 09/02/2026 to 09/04/2026

Read More+

EMA CVMP Meeting Highlights — 10–12 February 2026

18th February 2026

he European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) published outcomes from its February 2026 plenary meeting, covering new product opinions, variations, pharmacovigilance updates and draft guidance.

Read More+

EMA PRAC Meeting Highlights — 9–12 February 2026

18th February 2026

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) concluded a major safety review and issued key risk-management recommendations for human medicines.

Read More+

Global commitment on display as countries negotiate key annex to the Pandemic Agreement

18th February 2026

WHO Member States have shown strong unity in advancing negotiations on a critical annex to the global Pandemic Agreement aimed at improving pandemic preparedness and equity.

Read More+

Medical Devices Regulations – Targeted Consultation on the Indefinite Recognition of CE-Marked Devices

18th February 2026

The MHRA is consulting on proposals to allow CE-marked medical devices to be recognised indefinitely in Great Britain.

Read More+

Mock example developed to illustrate quality modules of ICH M4Q (R2) Common Technical Document

18th February 2026

The International Council for Harmonisation (ICH) has published a mock example to help stakeholders understand the revised quality modules in the updated CTD guideline.

Read More+

Timelines for acceptance of CE-marked medical devices in Great Britain (GB)

18th February 2026

MHRA has published expected timelines for when CE-marked medical devices and IVDs can continue to be accepted in Great Britain.

Read More+

Updates to Clinical Trials Regulations — Transitional Arrangements Guidance

18th February 2026

The MHRA has updated its clinical trials transitional guidance to clarify timelines and labelling requirements under the new UK clinical trial regime.

Read More+

Chemical Safety and Biosafety Progress Report

11th February 2026

February 2026 (OECD)

Read More+
« Previous | Page 4 of 131 | Next »

Share